N. Le Stang

发表

Deep learning-based classification of mesothelioma improves prediction of patient outcome

G. Wainrib, P. Courtiol, C. Maussion, 2019, Nature Medicine.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

N. Le Stang, N. Girard, A. Nicholson, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Molecular characterization of pleomorphic mesothelioma: a multi-institutional study

N. Le Stang, F. Galateau-Sallé, S. Dacic, 2021, Modern Pathology.

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas

N. Le Stang, F. Galateau-Sallé, M. Beasley, 2019, Modern Pathology.

PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better?

N. Le Stang, F. Galateau-Sallé, S. Lantuejoul, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[The French mesothelioma network from 1998 to 2013].

N. Le Stang, F. Galateau-Sallé, P. Hainaut, 2014, Annales de pathologie.

Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.

N. Le Stang, J. Raemaekers, E. Noordijk, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study

N. Le Stang, M. Macro, S. Bardet, 2006, Leukemia & lymphoma.

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer

N. Le Stang, S. Lantuejoul, F. Penault-Llorca, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study.

N. Le Stang, F. Galateau-Sallé, V. Bouvier, 2019, Cancer epidemiology.

The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

N. Le Stang, A. Borczuk, I. Wistuba, 2022, Journal of Thoracic Oncology.

Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.

N. Le Stang, N. Girard, F. Galateau-Sallé, 2020, Archives of pathology & laboratory medicine.

Solid papillary mesothelial tumor

N. Le Stang, F. Galateau-Sallé, S. Dacic, 2021, Modern Pathology.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Aurélie A G Gabriel, N. Le Stang, N. Girard, 2019, Nature Communications.

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.

N. Le Stang, F. Galateau-Sallé, J. V. van Meerbeeck, 2022, Molecular oncology.

MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma

N. Le Stang, F. Galateau-Sallé, S. Dacic, 2019, Modern Pathology.

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

N. Le Stang, F. Galateau-Sallé, G. Byrnes, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses

Erik N. Bergstrom, P. Courtiol, C. Maussion, 2021, bioRxiv.

Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.

N. Le Stang, F. Galateau-Sallé, G. Ferretti, 2016, Human pathology.

Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center.

G. Wainrib, P. Courtiol, C. Maussion, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer.

N. Le Stang, A. Nicholson, A. Borczuk, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition

N. Le Stang, F. Galateau-Sallé, J. V. van Meerbeeck, 2022, bioRxiv.

Cancer incidence and mortality in France over the period 1980-2005.

M Colonna, N. Le Stang, G. Hédelin, 2008, Revue d'epidemiologie et de sante publique.

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas

N. Le Stang, F. Galateau-Sallé, S. Lantuejoul, 2015, European Respiratory Journal.

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

N. Le Stang, F. Galateau-Sallé, M. Goldberg, 2010, International journal of cancer.

Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998-2002).

N. Le Stang, F. Galateau-Sallé, M. Goldberg, 2010, American journal of industrial medicine.

Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis

N. Le Stang, S. Lantuejoul, S. Lebecque, 2018, Cell Death & Disease.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

P. Courtiol, C. Maussion, N. Le Stang, 2023, Nature Genetics.

Multicenter harmonization study of pan-Trk immunohistochemistry for the detection of NTRK3 fusions.

N. Le Stang, A. Vincent-Salomon, S. Lantuejoul, 2023, Modern Pathology.

A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.

N. Le Stang, S. Dacic, F. Tirode, 2022, Archives of pathology & laboratory medicine.

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

N. Le Stang, G. Zalcman, E. Bergot, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis

N. Le Stang, S. Lantuejoul, S. Lebecque, 2018, Cell Death & Disease.

Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor

N. Le Stang, C. Sagan, V. Hofman, 2023, American Journal of Surgical Pathology.

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

N. Le Stang, G. Zalcman, E. Bergot, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.